Similar bypass rewiring via IGF1R has been described after prolonged EGFR inhibition in CCA [42] and after FGFR blockade in fusion-positive models [43, 44], suggesting convergent adaptive trajectories irrespective of the primary TKI. Here, IGF1R is linked to cholangiocarcinoma.